Enhertu

Imported from official source

Announcement

Safety Classified by Officially

Enhertu Active substance Trastuzumab deruxtecan Holder     Daiichi Sankyo Belgium N.V.-S.A Status Running Indication treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumours who have received prior treatment and who have no satisfactory treatment options Public documents Approbation   Information for the patient   Informed consent …

This is an extract. The publication continues at the source.

Read the original at the source: https://www.famhp.be/nl/menselijk_gebruik/geneesmiddelen/geneesmiddelen/onderzoek_ontwikkeling/gebruik_in_schrijnende_279

Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
Official source
https://www.famhp.be/en/rss.xml RSS
Imported
November 09, 2026 08:32
Versions
1 recorded
Identity
110438 at https://www.famhp.be

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.